Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).
Clinical trial NCT03647722 · TERMINATED
Trial details
- NCT number
- NCT03647722
- Sponsor
- University of Southern California
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-02
- Primary completion
- 2020-11-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.